raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:69

Amyloidosis

Type
Category
Group
Group of disorders
Age of onset
All ages
Status
active

A vast group of rare systemic diseases characterized by the presence of insoluble fibrillar protein deposits in tissues. Amyloidoses are classified according to biochemical type of amyloid protein involved.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAmyloidosis
frAmyloseAmyloïdose
deAmyloidose
esAmiloidosis
itAmiloidosi
nlAmyloïdose
ptAmiloidose
plAmyloidoza
csAmyloidóza
ukАмілоїдоз
zh淀粉样变性
trAmiloidoz

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10E85.0Especificvalidated
ICD-115D00Especificvalidated
MONDO0019065Evalidated
MONDO19065Evalidated
MeSHD000686Evalidated
UMLSC0002726Evalidated
MedDRA10002022Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (12):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET
Point prevalence1-9 / 100 0001.91 / 100 000Korea, Republic ofValue and classValidated28877709[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card